ArticleBlood2019

Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis.

Mostafa Belghasem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.